Breast Cancer Trial, Recruiting NCT07062458 Sponsor: Candiolo Cancer Institute - IRCCS Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Recruiting

NCT07062458
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Women aged 18 or older
  • People who have been diagnosed with early-stage breast cancer, or who have been identified as high risk for breast cancer (for example, those with BRCA1 or BRCA2 gene mutations)
  • People who have been assessed as suitable candidates for a type of mastectomy that preserves the nipple (called Nipple-Sparing Mastectomy)
  • People who are able to give informed consent to participate
  • People who have no medical reasons preventing them from having surgery, based on a physical examination and pre-surgery assessment
  • People who are willing to attend all scheduled follow-up appointments after the procedure

Who may not be able to join:

  • People who have had previous breast surgery
  • People who have had radiation therapy to the chest or breast area in the past
  • People with diabetes that is currently active or not well controlled
  • People with nerve conditions that may affect normal skin sensation
  • People whose cancer has been found to involve the nipple — either before or during surgery (in such cases, the treating surgeon would convert the procedure to a different type of mastectomy)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 13 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Giada Pozzi, MD, Candiolo Cancer Institute FPO-IRCCS

Phone: +39 011 9933017

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Candiolo Cancer Institute - IRCCS
Registry
ClinicalTrials.gov
Start date
1 June 2025
Est. completion
1 December 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

measurement of nipple sensation preservation

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov